BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6425870)

  • 1. Inhibition studies of microsomal UDP-glucuronosyltransferase activities by furosemide and salicylamide.
    Boutin JA; Thomassin J; Siest G; Batt AM
    Pharmacol Res Commun; 1984 Mar; 16(3):227-41. PubMed ID: 6425870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UDP-glucuronosyltransferase(s) activities towards natural substrates in rat liver microsomes. Kinetic properties and influence of triton X-100 activation.
    Thomassin J; Boutin JA; Siest G
    Pharmacol Res Commun; 1985 Nov; 17(11):1005-15. PubMed ID: 3937161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of hepatic microsomal UDP-glucuronosyltransferase activities. Conjugations of phenolic and monoterpenoid aglycones in control and induced rats and guinea pigs.
    Boutin JA; Thomassin J; Siest G; Cartier A
    Biochem Pharmacol; 1985 Jul; 34(13):2235-49. PubMed ID: 3925953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoaffinity labeling of rat liver microsomal morphine UDP-glucuronosyltransferase by [3H]flunitrazepam.
    Thomassin J; Tephly TR
    Mol Pharmacol; 1990 Sep; 38(3):294-8. PubMed ID: 2119476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and purification of rat liver morphine UDP-glucuronosyltransferase.
    Puig JF; Tephly TR
    Mol Pharmacol; 1986 Dec; 30(6):558-65. PubMed ID: 3097500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inhibition by diazepam and nitrazepam of UDP-glucuronyltransferase activities in rats.
    del Villar E; Sanchez E; Letelier ME; Vega P
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):433-47. PubMed ID: 6800002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low-dose phenobarbital on hepatic microsomal UDP-glucuronyl transferase activity.
    Tavoloni N; Wittman R; Jones MJ; Berk PD
    Biochem Pharmacol; 1983 Jul; 32(14):2143-7. PubMed ID: 6409115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic characteristics of UDP-glucuronosyltransferases towards a dithiol metabolite of malotilate in hepatic microsomes of rats and rabbits.
    Nakaoka M
    Xenobiotica; 1990 Jun; 20(6):619-27. PubMed ID: 2120856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of uridinediphosphate glucuronyltransferase caused by furosemide.
    Sörgel F; Beyhl FE; Mutschler E
    Experientia; 1980 Jul; 36(7):861-3. PubMed ID: 6772468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of paracetamol UDP-glucuronosyltransferase activity in human liver microsomes.
    Miners JO; Lillywhite KJ; Yoovathaworn K; Pongmarutai M; Birkett DJ
    Biochem Pharmacol; 1990 Aug; 40(3):595-600. PubMed ID: 2116803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species difference in codeine uridine diphosphate-glucuronyltransferase activity of liver microsomes.
    Hanioka N; Hoshikawa Y; Mitsui T; Oguri K; Yoshimura H
    J Pharmacobiodyn; 1990 Nov; 13(11):712-7. PubMed ID: 2128752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evidence for the involvement of at least two forms of human liver UDP-glucuronosyltransferase in morphine 3-glucuronidation.
    Miners JO; Lillywhite KJ; Birkett DJ
    Biochem Pharmacol; 1988 Jul; 37(14):2839-45. PubMed ID: 3134892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of UDP-glucuronosyltransferase activity by possible transition-state analogues in rat-liver microsomes.
    Noort D; Coughtrie MW; Burchell B; van der Marel GA; van Boom JH; van der Gen A; Mulder GJ
    Eur J Biochem; 1990 Mar; 188(2):309-12. PubMed ID: 2108023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and properties of a rat liver phenobarbital-inducible 4-hydroxybiphenyl UDP-glucuronosyltransferase.
    Styczynski P; Green M; Puig J; Coffman B; Tephly T
    Mol Pharmacol; 1991 Jul; 40(1):80-4. PubMed ID: 1906977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the pregnenolone-16 alpha-carbonitrile-inducible form of rat liver microsomal cytochrome P-450 and UDP-glucuronosyltransferase.
    Arlotto MP; Sonderfan AJ; Klaassen CD; Parkinson A
    Biochem Pharmacol; 1987 Nov; 36(22):3859-66. PubMed ID: 3120728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective induction of phase II drug metabolizing enzyme activities by quinolines and isoquinolines.
    Le HT; Franklin MR
    Chem Biol Interact; 1997 Mar; 103(3):167-78. PubMed ID: 9134007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional heterogeneity of UDP-glucuronosyltransferase activities in C57BL/6 and DBA/2 mice.
    Bock KW; Lilienblum W; Pfeil H
    Biochem Pharmacol; 1982 Apr; 31(7):1273-7. PubMed ID: 6807317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of rat UDP-glucuronosyltransferase and glutathione S-transferase activities by L-buthionine-S,R-sulfoximine without induction of cytochrome P-450.
    Manning BW; Franklin MR
    Toxicology; 1990 Dec; 65(1-2):149-59. PubMed ID: 2125759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation.
    Zucker K; Tsaroucha A; Olson L; Esquenazi V; Tzakis A; Miller J
    Ther Drug Monit; 1999 Feb; 21(1):35-43. PubMed ID: 10051052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of UDP-glucuronosyltransferase activity toward eugenol, using a gas chromatographic method of measurement.
    Boutin JA; Siest G; Batt AM; Solheim E; Scheline RR
    Anal Biochem; 1983 Nov; 135(1):201-7. PubMed ID: 6422795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.